📋 Tender Overview
Contract awarded for Successive supply of medicines - zdr26-a5 lot-0000, title: successive supply of medicines – zdr26-a5, description: successive supply of medicines – zdr26-a5 with the following active substances: amivantamab 3520mg vial and amivantamab 2400mg vial estimated value excluding vat: 1235806.15 eur.Successive supply of medicines - zdr26-a5